Impact of Attaining an Aggressive PK/PD Target with Continuous Infusion Beta-Lactams on the Clinical Efficacy of Targeted Therapy of Early Post-Transplant Gram-negative Infections in Critically Ill OLT Recipients. an Interim Analysis of a 3-Year Prospective, Observational, Study